Ozempic Faces Growing Wave of Lawsuits Over Safety Concerns
Novo Nordisk, the pharmaceutical company behind the blockbuster diabetes and weight-loss drug Ozempic, is facing mounting legal challenges as lawsuits alleging serious side effects continue to surge across the United States. Thousands of Cases Consolidated in Federal Court More than 2,000 lawsuits have now been consolidated into multidistrict litigation (MDL 3094), focusing on claims that Ozempic and other…